Related Experiment Video
Updated: Aug 5, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Management of Tuberculosis Infection: Current Situation, Recent Developments and Operational Challenges
Gino Agbota1,2, Maryline Bonnet1, Christian Lienhardt1,3
1University of Montpellier, TransVIHMI, Institut de Recherche pour le Développement (IRD), Institut National de la Santé et de la Recherche Médicale (INSERM), 34090 Montpellier, France.
Tuberculosis infection (TBI) affects 2 billion people globally. New diagnostics and short treatments are key to managing TBI and ending the TB epidemic.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Tuberculosis infection (TBI) represents a dynamic host-bacilli interaction, with 2 billion globally infected.
- 5-10% of infected individuals develop active TB disease, a risk amplified by factors like HIV co-infection.
- The End-TB strategy emphasizes programmatic TBI management to meet global elimination targets.
Purpose of the Study:
- To review the current landscape of tuberculosis infection management.
- To highlight recent advancements in TBI diagnostics and preventive therapies.
- To discuss operational challenges in TBI programmatic management.
Main Methods:
- Literature review of current TBI management strategies.
- Analysis of recent developments in diagnostic tools for differentiating TBI from active TB.
- Examination of novel short-course preventive treatment regimens.
Main Results:
- Significant global burden of TBI necessitates effective management strategies.
- Emerging diagnostic tests offer improved discrimination between latent infection and active disease.
- Short-course preventive treatments show promise in reducing TB progression.
Conclusions:
- Effective management of TBI is critical for achieving global TB elimination goals.
- Advancements in diagnostics and treatment are pivotal for controlling the TB epidemic.
- Addressing operational challenges is essential for successful TBI programmatic implementation.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

